(Q34660970)

3 August 2017

0 references

Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies (English)

1 reference

3 August 2017

0 references

1 reference

Guangli Du

1

1 reference

3 August 2017

Ziyu Song

series ordinal

2

1 reference

3 August 2017

Qin Zhang

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

6 April 2013

1 reference

3 August 2017

1 reference

3 August 2017

57

1 reference

3 August 2017

1

1 reference

3 August 2017

31-37

1 reference

The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Operating characteristics of a rank correlation test for publication bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Distribution, Determinants, and Prognostic Value of γ-Glutamyltransferase for All-Cause Mortality in a Cohort of Construction Workers from Southern Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Bias in meta-analysis detected by a simple, graphical test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

gamma-glutamyltransferase and pathogenesis of cardiovascular diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Measuring inconsistency in meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

γ-Glutamyltransferase predicts cardiovascular death among Japanese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Liver enzymes: potential cardiovascular risk markers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyl transferase: a novel cardiovascular risk biomarker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Oxidative stress and regulation of glutathione in lung inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

A position statement on NAFLD/NASH based on the EASL 2009 special conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Serum gamma glutamyl transpeptidase in relation to alcohol consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Elevated serum gamma-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Association of gamma-glutamyltransferase with cardiovascular risk: a prognostic outlook.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

Gamma glutamyl transferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.03.011

10.1016/J.YPMED.2013.03.011

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference